Bezos and Gates-backed startup testing mind-controlled computing on humans
Bezos and Gates-backed startup testing mind-controlled computing on humans
With support from Microsoft co-founder Bill Gates and Amazon founder Jeff Bezos, the US startup Synchron is developing brain interface technology that could revolutionize the lives of paralyzed individuals.
According to CNBC, Synchron is one of the new breed of businesses developing brain-computer interface technology.
With the Synchron Switch, patients can control technology with just their thoughts after having it inserted into their blood vessels.
According to the report, three people in the US and four in Australia have received testing of the experimental technique thus far.
“I’ve witnessed times when the patient’s ability to be somewhat more independent than previously is immensely pleasant and inspiring, whether it be between the patient and spouse or partner.
According to the report, Synchron was established in 2012 and is a part of the rapidly growing brain-computer interface (BCI) market.
Bezos and Gates-backed startup testing mind-controlled computing on humans
Brain impulses are translated into commands for external technologies by a BCI system.
According to the report, Oxley refers to the blood arteries as the “natural highways” into the brain, through which Synchron BCI is placed.
The Synchron stent Stentrode is implanted into a sizable vein close to the motor brain and equipped with microscopic sensors.
According to the study, the Stentrode is connected to an antenna that is placed beneath the skin in the chest and gathers raw brain data that is sent from the body to external devices.
With the use of Synchron’s technology, those suffering from severe paralysis or degenerative illnesses like ALS can once again interact with friends, family, and the outside world via texting, typing, or even using social media.
$75 million funding
The company disclosed a $75 million funding round in December of last year, in which Bezos and Gates’ investment firms participated.
In August 2020, Synchron was awarded the Breakthrough Device designation by the US Food and Drug Administration. This classification is given to medical devices that show the potential to enhance therapy for illnesses that are life-threatening or disabling.
According to the story, the company has not yet turned a profit, and a spokesman claimed that Synchron would not comment on the ultimate cost of the treatment.
Also READ
FTX crypto fraud victims to get their money back
WhatsApp Community (For Regular Updates)
Follow the Find Headline Community on WhatsApp:
https://chat.whatsapp.com/L3ZV44K42O1G4og4F2EoDP
I’m Hassan Saeed, a Clinical Psychology graduate deeply engaged in the realms of WordPress, blogging, and technology. I enjoy merging my psychological background with the digital landscape. Let’s connect and explore these exciting intersections!
